Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

InnovaQor, Inc. (INQR)

0.0001
0.0000
(0.00%)
As of April 24 at 4:00:00 PM EDT. Market Open.
Loading Chart for INQR
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0012 x --
  • Ask 0.0040 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0044
  • Volume 50,000
  • Avg. Volume 1,030
  • Market Cap (intraday) 24,495
  • Beta (5Y Monthly) -22.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

InnovaQor, Inc. provides information technology solutions and services to healthcare and laboratory customers in the United States. It offers M2Select, which is an electronic health record and patient management software; M2Pro, a custom built, cloud based, electronic health record for ambulatory physician practices; ClinLab, which is a turnkey client/server lab information system for mid-range laboratories; Qira, a healthcare business analytics tool; MedTuning that provides clinical decision support for physicians and personalized drug treatment for patients; and Advantage, a proprietary health insurance portability and accountability act compliant software to eliminate the need for paper requisitions. The company also offers virtual chief information officer comprising program and project management, vendor management, business continuity and disaster recovery, security services, network infrastructure management, and helpdesk provision, as well as IT managed services and data analytics dashboards. In addition, it offers medical support services primarily to clinical laboratories, corporate operations, rural hospitals, physician practices, and behavioral health/substance abuse centers. The company is based in West Palm Beach, Florida. InnovaQor, Inc. is a subsidiary of Rennova Health, Inc.

www.innovaqor.com

6

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INQR

View More

Performance Overview: INQR

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

INQR
0.00%
S&P 500 (^GSPC)
6.13%

1-Year Return

INQR
95.33%
S&P 500 (^GSPC)
9.37%

3-Year Return

INQR
98.31%
S&P 500 (^GSPC)
28.52%

5-Year Return

INQR
93.33%
S&P 500 (^GSPC)
94.64%

Compare To: INQR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INQR

View More

Valuation Measures

Annual
As of 4/24/2025
  • Market Cap

    24.50k

  • Enterprise Value

    1.75M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.04

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    3.17

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -2,043.68%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    549.78k

  • Net Income Avi to Common (ttm)

    -2.12M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.7k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -552.97k

Research Analysis: INQR

View More

Company Insights: INQR

Research Reports: INQR

View More

People Also Watch